Technical Analysis for PEN - Penumbra, Inc.

Grade Last Price % Change Price Change
grade B 136.57 1.72% 2.31
PEN closed up 1.72 percent on Friday, November 16, 2018, on 70 percent of normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical PEN trend table...

Date Alert Name Type % Chg
Nov 16 Slingshot Bearish Bearish Swing Setup 0.00%
Nov 16 Crossed Above 200 DMA Bullish 0.00%
Nov 16 Stochastic Buy Signal Bullish 0.00%
Nov 16 Oversold Stochastic Weakness 0.00%
Nov 15 NR7 Range Contraction 1.72%
Nov 15 Multiple of Ten Bullish Other 1.72%
Nov 15 Oversold Stochastic Weakness 1.72%
Nov 14 200 DMA Resistance Bearish 5.11%
Nov 14 MACD Bearish Centerline Cross Bearish 5.11%
Nov 14 MACD Bearish Signal Line Cross Bearish 5.11%

Older signals for PEN ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in United States, Japan, and internationally. The company offers neurovascular access products under the Neuron, Neuron MAX, Select, BENCHMARK, DDC, PXSLIM, and Velocity brands; and aspiration-based thrombectomy systems and accessory devices under the Penumbra System brand, as well as stent retriever for mechanical thrombectomy under the 3D brand. It also provides neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400 and Penumbra SMART Coil brands, as well as neurovascular stents under the LIBERTY Stent brand; neurosurgical tools for the removal of tissue and fluids under the Apollo System brand; detachable embolic coil systems for peripheral embolization under the RUBY Coil brand; detachable, microcatheter-deliverable occlusion devices under the POD (penumbra occlusion device) brand; and aspiration-based thrombectomy systems for peripheral applications under the Indigo System brand. The company sells its products through its salesforce and distributors to hospitals in the neuro and peripheral vascular markets. Penumbra, Inc. was founded in 2004 and is headquartered in Alameda, California.
Is PEN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 167.35
52 Week Low 82.55
Average Volume 365,222
200-Day Moving Average 134.8202
50-Day Moving Average 142.9288
20-Day Moving Average 140.0015
10-Day Moving Average 142.269
Average True Range 6.7851
ADX 17.14
+DI 23.578
-DI 27.0059
Chandelier Exit (Long, 3 ATRs ) 140.1447
Chandelier Exit (Short, 3 ATRs ) 149.3953
Upper Bollinger Band 153.68
Lower Bollinger Band 126.323
Percent B (%b) 0.37
BandWidth 19.540505
MACD Line -0.9215
MACD Signal Line 0.0806
MACD Histogram -1.0021
Fundamentals Value
Market Cap 4.62 Billion
Num Shares 33.8 Million
EPS 0.15
Price-to-Earnings (P/E) Ratio 910.47
Price-to-Sales 11.15
Price-to-Book 8.79
PEG Ratio -71.69
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 146.38
Resistance 3 (R3) 145.91 142.17 144.75
Resistance 2 (R2) 142.17 139.67 142.41 144.20
Resistance 1 (R1) 139.37 138.13 140.77 139.84 143.65
Pivot Point 135.63 135.63 136.33 135.87 135.63
Support 1 (S1) 132.83 133.13 134.23 133.30 129.49
Support 2 (S2) 129.09 131.59 129.33 128.94
Support 3 (S3) 126.29 129.09 128.40
Support 4 (S4) 126.76